The Role of TRAF4 and B3GAT1 Gene Expression in the Food Hypersensitivity and Insect Venom Allergy in Mastocytosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1661-4917
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The Role of TRAF4 and B3GAT1 Gene Expression in the Food Hypersensitivity and Insect Venom Allergy in Mastocytosis ; day:16 ; month:4 ; year:2016 ; pages:1-7
Archivum immunologiae et therapiae experimentalis ; (16.4.2016), 1-7
- Urheber
-
Górska, Aleksandra
- Beteiligte Personen und Organisationen
-
Gruchała-Niedoszytko, Marta
Niedoszytko, Marek
Maciejewska, Agnieszka
Chełmińska, Marta
Skrzypski, Marcin
Wasąg, Bartosz
Kaczkan, Małgorzata
Lange, Magdalena
Nedoszytko, Bogusław
Pawłowski, Ryszard
Małgorzewicz, Sylwia
Jassem, Ewa
SpringerLink (Online service)
- DOI
-
10.1007/s00005-016-0397-7
- URN
-
urn:nbn:de:1111-201604187784
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Górska, Aleksandra
- Gruchała-Niedoszytko, Marta
- Niedoszytko, Marek
- Maciejewska, Agnieszka
- Chełmińska, Marta
- Skrzypski, Marcin
- Wasąg, Bartosz
- Kaczkan, Małgorzata
- Lange, Magdalena
- Nedoszytko, Bogusław
- Pawłowski, Ryszard
- Małgorzewicz, Sylwia
- Jassem, Ewa
- SpringerLink (Online service)
Ähnliche Objekte (12)
Current challenges in molecular diagnostics of insect venom allergy
Healthcare provision for insect venom allergy patients during the COVID-19 pandemic
Hymenoptera venom allergy: venom proteomes and patient transcriptomes
Quality-of-life in insect venom allergy: validation of the Turkish version of the “Vespid Allergy Quality of Life Questionnaire” (VQLQ-T)
Hymenoptera venom allergy in children
Proteomic features characterization of Hymenoptera venom allergy
Recombinant strategies in hymenoptera venom allergy and beyond
Effects of a 90-min educational intervention for patients with insect venom allergy: a prospective controlled pilot study
Risk factors in bee and Vespula venom allergy: state of the art
Risk factors in bee and Vespula venom allergy: state of the art
PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy
Important questions in drug allergy and hypersensitivity: consensus papers from the 2018 AAAAI/WAO international drug allergy symposium
Current challenges in molecular diagnostics of insect venom allergy
Healthcare provision for insect venom allergy patients during the COVID-19 pandemic
Hymenoptera venom allergy: venom proteomes and patient transcriptomes
Quality-of-life in insect venom allergy: validation of the Turkish version of the “Vespid Allergy Quality of Life Questionnaire” (VQLQ-T)
Hymenoptera venom allergy in children
Proteomic features characterization of Hymenoptera venom allergy
Recombinant strategies in hymenoptera venom allergy and beyond
Effects of a 90-min educational intervention for patients with insect venom allergy: a prospective controlled pilot study
Risk factors in bee and Vespula venom allergy: state of the art
Risk factors in bee and Vespula venom allergy: state of the art
PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy
Important questions in drug allergy and hypersensitivity: consensus papers from the 2018 AAAAI/WAO international drug allergy symposium
Current challenges in molecular diagnostics of insect venom allergy
Healthcare provision for insect venom allergy patients during the COVID-19 pandemic
Hymenoptera venom allergy: venom proteomes and patient transcriptomes
Quality-of-life in insect venom allergy: validation of the Turkish version of the “Vespid Allergy Quality of Life Questionnaire” (VQLQ-T)
Hymenoptera venom allergy in children
Proteomic features characterization of Hymenoptera venom allergy
Recombinant strategies in hymenoptera venom allergy and beyond
Effects of a 90-min educational intervention for patients with insect venom allergy: a prospective controlled pilot study
Risk factors in bee and Vespula venom allergy: state of the art
Risk factors in bee and Vespula venom allergy: state of the art
PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy